Modulation of insulin/IGFs pathways by sirtuin-7 inhibition in drug-induced chemoreistance

Diagnostic Pathology

Volumn 9, Issue 1, 2014, Pages

  Aljada, Ahmad ^a,b   Saleh, Ayman M ^a,b   Al Suwaidan, Salem ^b  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Drug induced resistance; Insulin IGF; Sirtuin 7; Stress induced premature senescence

Indexed keywords

INSULIN; SIRT7 PROTEIN, HUMAN; SIRTUIN; SOMATOMEDIN;

DRUG RESISTANCE; GENETIC TRANSFECTION; HUMAN; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HUMANS; INSULIN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SIRTUINS; SOMATOMEDINS; TRANSFECTION;

EID: 84922672604     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-9-94     Document Type: Article

References (55)

1. Zapf J, Froesch ER: Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. Horm Res 1986, 24:121-130
2. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990, 50:48-53
3. Gross GE, Boldt DH, Osborne CK: Perturbation by insulin of human breast cancer cell cycle kinetics. Cancer Res 1984, 44:3570-3575
4. Myal Y, Shiu RP, Bhaumick B, Bala M: Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Res 1984, 44:5486-5490
5. Rasmussen AA, Cullen KJ: Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Res Treat 1998, 47:219-233
6. Goustin AS, Leof EB, Shipley GD, Moses HL: Growth factors and cancer. Cancer Res 1986, 46:1015-1029
7. van Wyk JJ, Graves DC, Casella SJ, Jacobs S: Evidence from monoclonal antibody studies that insulin stimulates deoxyribonucleic acid synthesis through the type I somatomedin receptor. J Clin Endocrinol Metab 1985, 61:639-643
8. Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, Mulshine JL, Cuttitta F: Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 1996, 271:11477-11483
9. Surmacz E, Guvakova MA, Nolan MK, Nicosia RF, Sciacca L: Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res Treat 1998, 47:255-267
10. Nakanishi Y, Mulshine JL, Kasprzyk PG, Natale RB, Maneckjee R, Avis I, Treston AM, Gazdar AF, Minna JD, Cuttitta F: Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 1988, 82:354-359
11. Wong M, Holdaway IM: Insulin binding by normal and neoplastic colon tissue. Int J Cancer 1985, 35:335-341
12. Mountjoy KG, Holdaway IM, Finlay GJ: Insulin receptor regulation in cultured human tumor cells. Cancer Res 1983, 43:4537-4542
13. Pavelic K, Popovic M: Insulin and glucagon secretion by renal adenocarcinoma. Cancer 1981, 48:98-100
14. Oleesky S, Bailey I, Samols E, Bilkus D: A fibrosarcoma with hypoglycaemia and a high serum-insulin level. Lancet 1962, 2:378-380
15. Pavelic K, Odavic M, Pekic B, Hrsak I, Vuk-Pavlovic S: Correlation of substance (s) immunologically cross-reactive with insulin, glucose and growth hormone in Hodgkin lymphoma patients. Cancer Lett 1982, 17:81-86
16. Colman PG, Harrison LC: Structure of insulin/insulin-like growth factor-1 receptors on the insulinoma cell, RIN-m5F. Biochem Biophys Res Commun 1984, 124:657-662
17. Holdaway IM, Friesen HG: Hormone binding by human mammary carcinoma. Cancer Res 1977, 37:1946-1952
18. Papa V, Milazzo G, Goldfine ID, Waldman FM, Vigneri R: Sporadic amplification of the insulin receptor gene in human breast cancer. J Endocrinol Invest 1997, 20:531-536
19. Lippman ME, Dickson RB, Kasid A, Gelmann E, Davidson N, McManaway M, Huff K, Bronzert D, Bates S, Swain S: Autocrine and paracrine growth regulation of human breast cancer. J Steroid Biochem 1986, 24:147-154
20. de Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL: M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 1995, 11:447-449
21. Belfiore A: The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des 2007, 13:671-686
22. Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R: The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 2008, 114:23-37
23. So AI, Levitt RJ, Eigl B, Fazli L, Muramaki M, Leung S, Cheang MC, Nielsen TO, Gleave M, Pollak M: Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer. Clin Cancer Res 2008, 14:6944-6954
24. Levitt RJ, Georgescu MM, Pollak M: PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2. Biochem Biophys Res Commun 2005, 336:1056-1061
25. Ford E, Voit R, Liszt G, Magin C, Grummt I, Guarente L: Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev 2006, 20:1075-1080
26. Aljada A, Saleh A, Mousa S: Induction of stress induced premature senescence by sirtuin-7 inhibition: a novel mechanism for multi drug resistance. J Cancer Sci Ther 2013, In Press
27. Kenyon C: A conserved regulatory system for aging. Cell 2001, 105:165-168
28. Longo VD, Finch CE: Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 2003, 299:1342-1346
29. Bluher M, Kahn BB, Kahn CR: Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003, 299:572-574
30. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le Bouc Y: IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187
31. Taguchi A, Wartschow LM, White MF: Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 2007, 317:369-372
32. Majeed N, Blouin MJ, Kaplan-Lefko PJ, Barry-Shaw J, Greenberg NM, Gaudreau P, Bismar TA, Pollak M: A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model. Oncogene 2005, 24:4736-4740
33. Wu Y, Cui K, Miyoshi K, Hennighausen L, Green JE, Setser J, LeRoith D, Yakar S: Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Cancer Res 2003, 63:4384-4388
34. Creighton CJ, Casa A, Lazard Z, Huang S, Tsimelzon A, Hilsenbeck SG, Osborne CK, Lee AV: Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 2008, 26:4078-4085
35. Warshamana-Greene GS, Litz J, Buchdunger E, Hofmann F, Garcia-Echeverria C, Krystal GW: The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling. Mol Cancer Ther 2004, 3:527-535
36. Warshamana-Greene GS, Litz J, Buchdunger E, Garcia-Echeverria C, Hofmann F, Krystal GW: The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy. Clin Cancer Res 2005, 11:1563-1571
37. Vincent AM, Feldman EL: Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 2002, 12:193-197
38. Geng M, Wang L, Chen X, Cao R, Li P: The association between chemosensitivity and Pgp, GST-pi and Topo II expression in gastric cancer. Diagn Pathol 2013, 8:198
39. Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ: Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 1987, 84:7716-7719
40. Griswold AJ, Chang KT, Runko AP, Knight MA, Min KT: Sir2 mediates apoptosis through JNK-dependent pathways in Drosophila. Proc Natl Acad Sci USA 2008, 105:8673-8678
41. Naka K, Tachibana A, Ikeda K, Motoyama N: Stress-induced premature senescence in hTERT-expressing ataxia telangiectasia fibroblasts. J Biol Chem 2004, 279:2030-2037
42. Wang L, Li PF, Geng M, Cao YC, Yin YC: Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer. Diagn Pathol 2013, 8:33
43. Jackson JG, Zhang X, Yoneda T, Yee D: Regulation of breast cancer cell motlity by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Oncogene 2001, 20:7318-7325
44. Grothey A, Voigt W, Schober C, Muller T, Dempke W, Schmoll HJ: The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis and chemoresistance in solid tumors. Cancer Res Clin Oncol 1999, 125:166-173
45. Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D: Circulating Insuling-like growth factor-I levels regulate Colon cancer growth and metastasis. Cancer Res 2002, 62:1030-1035
46. Dunn SE, Ehrlich M, Sharp NJ, Reiss K, Solomon G, Hawkins R, Baserga R, Barrett JC: A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res 1998, 58:3353-3361
47. Burger H, Nooter K, Boersma AW, Kortland CJ, Stoter G: Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. Br J Cancer 1998, 77:1562-1567
48. Burger H, Nooter K, Boersma AW, Kortland CJ, van den Berg AP, Stoter G: Expression of p53, p21/WAF/CIP, Bcl-2, Bax, Bcl-x, and Bak in radiation-induced apoptosis in testicular germ cell tumor lines. Int J Radiat Oncol Biol Phys 1998, 41:415-424
49. Zamble DB, Jacks T, Lippard SJ: p53-Dependent and-independent responses to cisplatin in mouse testicular teratocarcinoma cells. Proc Natl Acad Sci USA 1998, 95:6163-6168
50. Dunn SE, Hardman RA, Kari FW, Barrett JC: Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res 1997, 57:2687-2693
51. Lasalvia-Prisco E, Cucchi S, Vazquez J, Lasalvia-Galante E, Golomar W, Gordon W: Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients. Cancer Chemother Pharmacol 2004, 53:220-224
52. Ayre SG, Garcia y Bellon DP, Garcia DP Jr: Insulin, chemotherapy, and the mechanisms of malignancy: the design and the demise of cancer. Med Hypotheses 2000, 55:330-334
53. Alabaster O, Vonderhaar BK, Shafie SM: Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol 1981, 17:1223-1228
54. Schilsky RL, Bailey BD, Chabner BA: Characteristics of membrane transport of methotrexate by cultured human breast cancer cells. Biochem Pharmacol 1981, 30:1537-1542
55. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID, Vigneri R: Elevated insulin receptor content in human breast cancer. J Clin Invest 1990, 86:1503-1510